“A complete breakdown in communication and coordination within the Trump administration has undermined the distribution of a promising treatment,” Axios reports.
‘The drug, remdesivir, hasn’t made it to some of the high-priority hospitals where it’s most needed, and administration officials have responded by shifting blame and avoiding responsibility.”
Save to Favorites